| Positive Rankings |
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, La Jolla Pharmaceutical Company is ranked 131. |
Low vPut/Call
La Jolla Pharmaceutical Company has a low Put/Call ratio of 0.32 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, La Jolla Pharmaceutical Company is ranked 722. |
Debt-to-Equity
La Jolla Pharmaceutical Company rank is 795 |
| Negative Rankings |
Negative Net Margin
La Jolla Pharmaceutical Company rank is 61 |
Price-to-Sales
La Jolla Pharmaceutical Company rank is 69 |
Down EPS Surprise
La Jolla Pharmaceutical Company missed the consensus earnings estimate when it last reported quarterly earnings. |
Negative ROE
La Jolla Pharmaceutical Company rank is 255 |
High Put/Call
La Jolla Pharmaceutical Company has a high Put/Call ratio of 1.84 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, La Jolla Pharmaceutical Company is ranked 260. |
Negative ROA
La Jolla Pharmaceutical Company rank is 275 |
90 Day Loss
La Jolla Pharmaceutical Company rank is 418 |
Negative Cash Growth
La Jolla Pharmaceutical Company rank is 656 |
10 Day Loss
La Jolla Pharmaceutical Company rank is 923 |
Price-to-Book
La Jolla Pharmaceutical Company rank is 977 |
